Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1980 Apr;4:222–225.

Toxicity to tumour cells of diethylaminoreserpine.

S Lehnert
PMCID: PMC2149265  PMID: 6932928

Abstract

Diethylaminoreserpine (DL-152), an inhibitor of cyclic AMP phosphodiesterase, has been shown to kill clonogenic cells of the KHT fibrosarcoma when the drug is given intraperitoneally to the tumour-bearing mouse. DL-152 shows a greater toxicity to acutely hypoxic cells than to aerated cells. Following DL-152 injection, the number of surviving clonogenic tumour cells fell progressively until a minimum level was reached at 48 h after injection; repopulation commenced immediately and proceeded rapidly. The extent of cell killing following DL-152 injection was directly proportional to the size of the tumour at the time of treatment. A single injection of DL-152 produced no measurable change in the growth rate of small tumours. Treatment of larger tumours however, induced a period of slow growth followed by a return to the rate of growth observed in controls.

Full text

PDF
222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GARATTINI S., LAMESTA L., MORTARI A., VALZELLI L. Pharmacological and biochemical effects of some reserpine derivatives. J Pharm Pharmacol. 1961 Sep;13:548–553. doi: 10.1111/j.2042-7158.1961.tb11868.x. [DOI] [PubMed] [Google Scholar]
  2. Honda F., Imamura H. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by phenothiazine and reserpine derivatives. Biochim Biophys Acta. 1968 Jun 18;161(1):267–269. doi: 10.1016/0005-2787(68)90321-3. [DOI] [PubMed] [Google Scholar]
  3. Kallman R. F., Silini G., Van Putten L. M. Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. J Natl Cancer Inst. 1967 Sep;39(3):539–549. [PubMed] [Google Scholar]
  4. Lehnert S. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase. Int J Radiat Oncol Biol Phys. 1979 Jun;5(6):825–833. doi: 10.1016/0360-3016(79)90067-1. [DOI] [PubMed] [Google Scholar]
  5. Nelson J. S., Carpenter R. E., Parker R. G. Response of mouse skin and the C3HBA mammary carcinoma of the C3H mouse to x-rays and cyclotron neutrons: effect of mixed neutron-photon fractionation schemes. Eur J Cancer. 1975 Dec;11(12):891–901. doi: 10.1016/0014-2964(75)90090-0. [DOI] [PubMed] [Google Scholar]
  6. Rockwell S. C., Kallman R. F., Fajardo L. F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst. 1972 Sep;49(3):735–749. [PubMed] [Google Scholar]
  7. Thomson J. E., Rauth A. M. An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiat Res. 1974 May;58(2):262–276. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES